At ADAMAS we have made a commitment to all our clients to ensure safe, accurate and secure retention of critical information relating to the services we have provided. For example, the final version of audit reports as well as the CV and Training Record of the...
This piece is an extract of the upcoming ADAMAS white paper “Making the Model: Solving the Data Integrity Challenge of Decentralized Clinical Trials”. It may be easy to think that Decentralized Clinical Trials (DCCTs) have emerged because of the necessity to fit...
At ADAMAS, our mission is to provide our clients with best-in-class expertise; our team consists of the top industry knowledge of clinical quality assurance. But we go even further beyond that, to ensure that we remain true partners to our clients, working with your...
For over two decades ADAMAS has shown an unwavering commitment to being a market leader that sets the standard for best in class service. Part of being an innovator is to be continuously looking at how we can improve. We must always be evaluating not only our services...
Did you know that ADAMAS has made significant investment in compliance with international data privacy and security requirements, in ways that may not be reflected by other smaller organisations or freelancers? For example, all of ADAMAS’s activities are governed by a...
ADAMAS Consulting is delighted to announce the opening of our new office located in San Diego, California. ADAMAS brings 23 years of thought leadership in Quality Assurance to the American West. The challenging year the industry has collectively faced has driven the...
It has been nearly four years since the release of ICH E6 (R2) in November 2016, however a recent poll on status of ICH E6 (R2) showed only 5% of companies as having implemented the addendum, with the top two hurdles being implementation of Risk Based Quality...
Did you know that ADAMAS provides an enhanced level of compliance that you may not find when selecting other contract QA organisations or small/solo contractors? ADAMAS has made a significant investment in ‘state of the art’ compliance infrastructure and processes,...
Could a second, potentially more contagious wave, of COVID-19 bring further disruption to travel and clinical trial activities? Is it possible to meet the current oversight and compliance expectations of regulatory authorities? We are all aware of the initial impact...
It’s a tough choice – new drugs for patients or the health and safety of your valued staff? With ADAMAS Consulting, you do not have to choose. As we keep hearing these are unprecedented times, and just recently there have been concerning articles in the scientific...